|
|
Immuron Limited - Earning & Dividend Analysis Snapshot
This detailed Report provides an Earnings and Dividends history for Immuron Limited. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.
Immuron Limited Formerly known as Anadis Limited. The Company's principal activity is engaging in biopharmaceutical research, focusing on the use of polyclonal antibodies for the treatment and prevention of major diseases. Its products are antibody-containing products which target diseases including HIV/AIDS, Influenza, Mucositis related to cancer and gastrointestinal infections from Clostridium difficile (c. difficile), Escherichia colii (e.coli) and rotavirus. The Company operates Australia.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|